A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Viatris Inc stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 369 shares of VTRS stock, worth $4,619. This represents 0.0% of its overall portfolio holdings.

Number of Shares
369
Previous 437 15.56%
Holding current value
$4,619
Previous $4.65 Million 7.77%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.32 - $12.13 $701 - $824
-68 Reduced 15.56%
369 $4.29 Million
Q2 2024

Aug 12, 2024

BUY
$10.05 - $12.02 $432 - $516
43 Added 10.91%
437 $4.65 Million
Q1 2024

May 13, 2024

BUY
$11.27 - $13.53 $912 - $1,095
81 Added 25.88%
394 $4.71 Million
Q4 2023

Feb 09, 2024

SELL
$8.77 - $10.85 $745 - $922
-85 Reduced 21.36%
313 $3.39 Million
Q3 2023

Nov 08, 2023

BUY
$9.59 - $11.35 $3,816 - $4,517
398 New
398 $3.93 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Annis Gardner Whiting Capital Advisors, LLC Portfolio

Follow Annis Gardner Whiting Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annis Gardner Whiting Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annis Gardner Whiting Capital Advisors, LLC with notifications on news.